| Penpulimab in Combination With Cetuximab as First-line Treatment in R/M SCCHN (NCT05260671) | Eye & ENT Hospital of Fudan University | 2022-01-25 |
| Palbociclib in Combination With Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LL) (NCT03792256) | Children's Oncology Group | 2019-04-11 |
| Stepped-Care Telehealth for Distress in Cancer Survivors (NCT03060096) | Wake Forest University Health Sciences | 2018-07-19 |
| A Study of Anlotinib in Recurrent/Metastatic Head and Neck Adenocarcinomas (NCT03591666) | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | 2018-07-15 |
| Study to Evaluate the Safety and Activity (Including Distribution) of 177Lu-3BP-227 in Subjects With Solid Tumours Expressing Neurotensin Receptor Type 1. (NCT03525392) | Ipsen | 2018-05-03 |
| Peptide Receptor Radionuclide Therapy With 90Y-Dotatoc in Relapsed/Refractory Diffuse Large B Cell and Mantle Cell Lymphomas (NCT02488512) | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | 2016-12-22 |
| Study of Ibrutinib in Combination With Bendamustine and Rituximab for Patients With Relapsed/Refractory Aggressive BCL (NCT02747732) | Meirav Kedmi MD | 2016-12-01 |
| Proton Beam Re-Irradiation in Thoracic Cancers (NCT02204761) | University of Washington | 2014-09-09 |
| Denosumab: A Potential Treatment Option for Aneurysmal Bone Cysts (NCT03415477) | Peking University People's Hospital | 2014-01-01 |
| Cetuximab + Taxotere With Low Dose Fractionated Radiation for Head and Neck Carcinoma (NCT01794845) | University of Miami | 2013-06-03 |
| Activity and Safety Study of BKM120 in Monotherapy in Patient With Metastatic Head and Neck Cancer Recurrent or Progressive (NCT01737450) | Centre Leon Berard | 2013-01-01 |
| Efficacy of SU 011248 in Head And Neck Carcinoma (NCT00408252) | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 2007-02-01 |
| Tipifarnib and Bortezomib in Treating Patients With Acute Leukemia or Chronic Myelogenous Leukemia in Blast Phase (NCT00383474) | National Cancer Institute (NCI) | 2006-08-01 |
| Belinostat and Azacitidine in Treating Patients With Advanced Hematologic Cancers or Other Diseases (NCT00351975) | National Cancer Institute (NCI) | 2006-06-01 |
| Sorafenib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Leukemia (NCT01445080) | National Cancer Institute (NCI) | 2006-05-30 |
| Fludarabine Phosphate and Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia That Has Responded to Treatment With Imatinib Mesylate, Dasatinib, or Nilotinib (NCT00036738) | Fred Hutchinson Cancer Center | 2001-07-13 |
| Tipifarnib in Treating Patients With Chronic Myeloid Leukemia, Chronic Myelomonocytic Leukemia, or Undifferentiated Myeloproliferative Disorders (NCT02210858) | National Cancer Institute (NCI) | 2000-05-01 |
| Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Older Patients With Chronic Myeloid Leukemia (NCT00003145) | Fred Hutchinson Cancer Center | 1997-08-01 |